Joshi Venugopal

General Manager, Head of Europe for Gene Therapies and Rare Diseases • Novartis Gene Therapies

Joshi Venugopal is the Head of Europe for the Rare Disease stand-alone unit of Novartis. Prior to his current role, he was the Global Head of New Products, where he played an instrumental role in the strategic pivot of Novartis to focus on US market, fewer therapeutic areas and larger products. Joshi has gained an incredible breadth of experience having worked in research, development, global marketing, global medical affairs, and country management at Novartis. He was also the Chief of Staff to the Chairman of Novartis from 2010 to 2012.

Joshi has lived in 9 countries and is interested in the strategic discourse on topics related to healthcare. He has published in The Financial Times and was a TEDx speaker. Joshi holds a PhD in Cell Biology from the University of Basel (Switzerland) and is an alumnus of the Harvard Business School (USA).

Also speaking

David Sourdive

Co-Founder, Executive Vice President CMC & Manufacturing • Cellectis

Ann-Hunter Van Kirk

Senior Equity Research Analyst Biopharmaceuticals • Bloomberg Intelligence

Emmanuelle Cameau

Strategic Technology Partnership Leader • Cytiva

Event Info


Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.